, Tracking Stock Market Picks
Enter Symbol:
Uroplasty, Inc. (UPI) [hlAlert]

down 68.36 %

Uroplasty, Inc. (UPI) upgraded to Buy with price target $6 by Dougherty & Company

Posted on: Wednesday,  Jan 22, 2014  2:25 PM ET by Dougherty & Company

Dougherty & Company rated Buy Uroplasty, Inc. (NASDAQ: UPI) on 01/22/2014, when the stock price was $3.54.
Since then, Uroplasty, Inc. has lost 68.36% as of 03/31/2015's recent price of $1.12.
If you would have followed this Dougherty & Company 's recommendation on UPI, you would have lost 68.36% of your investment in 433 days.

Uroplasty, Inc. (Uroplasty) is a medical device company that develops, manufactures and markets products for the treatment of voiding dysfunctions. Uroplasty offers the Urgent PC system, which is the only United States Food and Drug Administration (FDA) approved minimally invasive, office-based neurostimulation therapy for the treatment of urinary symptoms, urinary urgency, urinary frequency, and urge incontinence often associated with overactive bladder (OAB). Uroplasty also offers Macroplastique, a minimally invasive, implantable soft tissue urethral bulking agent for the treatment of adult female stress urinary incontinence. When Macroplastique is injected into tissue around the urethra, it stabilizes and bulks tissues, providing the surrounding muscles with increased capability to control the release of urine.

Team The research group is composed of five senior analysts and two associate analysts. The senior analysts collectively have 44 years of securities industry experience, and include 3 MBA's, 2 CPA's, 2 PE's (professional engineer), a CFA and a CMA. The team has come together out of a passion for overlooked or misunderstood investment opportunities – generally in smaller-cap companies – and a love of in-depth research, with special emphasis on independent information sources and innovative thinking. Coverage Our research coverage is idea driven and balances the twin demands of opportunism for flexibility and universe consistency for maximization of information sources. Current sub-sectors of interest include: * Specialty retail * Internet security * Internet media * Auto-identification and data capture (AIDC & RFID) * Mobile computing * Specialty manufacturing * Chronic care management * Outpatient services * Medical devices * Healthcare IT
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
1/22/2014 2:25 PM Buy
3.54 6.00
as of 10/17/2014
1 Week down  -7.53 %
1 Month down  -10.52 %
3 Months down  -17.22 %
1 YTD down  -37.57 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
1/25/2013 12:25 PM Hold
3/30/2012 10:25 AM Buy
3.06 5.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy